HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...

Argenx (ARGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of its ambulatory infusion suite (AIS) in Fort Wayne, further expanding its ...

Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...

Argenx (NASDAQ: ARGX) has been upgraded to an "outperform" rating from "underperform" by Bernstein, with the price target revised sharply upwards to €755 from 1 ...

Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase) is the first drug in the FcRn blocker class to treat CIDP, a rare autoimmune disease of the peripheral nervous system that causes fatigue ...

Daniel Cooper, assistant director for blood donation operations, said: “Thanks to our amazing blood and plasma donors in ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

The COVID-19 pandemic had a greater effect on the mental health of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN) than patients with motor ...

HC Wainwright reaffirmed their buy rating on shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) in a report issued ...

Guggenheim reiterated their buy rating on shares of Immunovant (NASDAQ:IMVT – Free Report) in a report issued on Monday ...